Borges Luis
Insider CIK 1684015 · FPRX SVP, Research · MGX Chief Scientific Officer · IPSC Chief Scientific Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MGX Metagenomi, Inc. | A Award deriv | 2024-04-01 | 2024-04-03 | 291,450 | — | $0 | 291,450 | SEC↗ |
| MGX Metagenomi, Inc. | A Award | 2024-04-01 | 2024-04-03 | 69,316 | — | $0 | 69,316 | SEC↗ |
| IPSC Century Therapeutics, Inc. | M Exercise deriv | 2023-04-03 | 2023-04-05 | 7,452 | — | $0 | 0 | SEC↗ |
| IPSC Century Therapeutics, Inc. | M Exercise | 2023-04-03 | 2023-04-05 | 7,452 | $1.03 | $7.7K | 256,535 | SEC↗ |
| IPSC Century Therapeutics, Inc. | M Exercise deriv | 2023-03-23 | 2023-03-23 | 220,930 | — | $0 | 7,452 | SEC↗ |
| IPSC Century Therapeutics, Inc. | M Exercise | 2023-03-23 | 2023-03-23 | 220,930 | $1.03 | $227.6K | 264,680 | SEC↗ |
| IPSC Century Therapeutics, Inc. | S Sale | 2023-03-23 | 2023-03-23 | 15,597 | $3.55 | $55.4K | 249,083 | SEC↗ |
| IPSC Century Therapeutics, Inc. | M Exercise deriv | 2023-03-22 | 2023-03-23 | 65,698 | — | $0 | 228,382 | SEC↗ |
| IPSC Century Therapeutics, Inc. | S Sale | 2023-03-22 | 2023-03-23 | 65,698 | $3.72 | $244.4K | 43,750 | SEC↗ |
| IPSC Century Therapeutics, Inc. | M Exercise | 2023-03-22 | 2023-03-23 | 65,698 | $1.03 | $67.7K | 109,448 | SEC↗ |
| IPSC Century Therapeutics, Inc. | M Exercise deriv | 2023-03-21 | 2023-03-23 | 63,616 | — | $0 | 294,080 | SEC↗ |
| IPSC Century Therapeutics, Inc. | S Sale | 2023-03-21 | 2023-03-23 | 63,616 | $3.77 | $239.8K | 43,750 | SEC↗ |
| IPSC Century Therapeutics, Inc. | M Exercise | 2023-03-21 | 2023-03-23 | 63,616 | $1.03 | $65.5K | 107,366 | SEC↗ |
| IPSC Century Therapeutics, Inc. | A Award deriv | 2023-02-02 | 2023-02-06 | 131,250 | — | $0 | 131,250 | SEC↗ |
| IPSC Century Therapeutics, Inc. | A Award deriv | 2023-02-02 | 2023-02-06 | 131,250 | — | $0 | 131,250 | SEC↗ |
| IPSC Century Therapeutics, Inc. | A Award | 2023-02-02 | 2023-02-06 | 21,875 | — | $0 | 21,875 | SEC↗ |
| IPSC Century Therapeutics, Inc. | A Award | 2023-02-02 | 2023-02-06 | 21,875 | — | $0 | 43,750 | SEC↗ |
| IPSC Century Therapeutics, Inc. | A Award deriv | 2022-01-25 | 2022-01-27 | 105,000 | — | $0 | 105,000 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | F Tax w/h | 2017-03-01 | 2017-03-03 | 18,084 | $44.77 | $809.6K | 64,888 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award deriv | 2017-02-07 | 2017-02-09 | 25,000 | — | $0 | 25,000 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award | 2017-02-07 | 2017-02-09 | 5,625 | — | $0 | 75,941 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award | 2017-02-07 | 2017-02-09 | 7,031 | — | $0 | 82,972 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | F Tax w/h | 2017-01-03 | 2017-01-05 | 1,306 | $48.60 | $63.5K | 70,316 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award deriv | 2016-09-08 | 2016-09-12 | 25,000 | — | $0 | 25,000 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award | 2016-09-08 | 2016-09-12 | 5,000 | — | $0 | 71,622 | SEC↗ |